James Walker currently serves as the Director of CMC Process Development at Arrowhead Pharmaceuticals, having joined in March 2024. Previously, James held various roles at SAFC from May 2016 to March 2024, including Associate Director and Principal Scientist, overseeing the development of cGMP intermediates and enhancing clients' clinical development efforts. James began his career as a Scientist at FLX Bio, Inc. and Flexus Biosciences, and was a PhD Candidate at Stanford University, focusing on organic synthesis of guanidinium toxins. Academic qualifications include a PhD in Chemistry and Chemical Biology from Stanford University and a Bachelor's degree with first-class honors in Chemistry and Biochemistry from Queensland University of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices